5VM
5AM Venture Management Portfolio holdings
AUM
$260M
1-Year Est. Return
3.76%
1 Year Est. Return
+3.76%
AUM
$260M
AUM Growth
-$4.29M
(-1.6%)
Holding
31
Top Buys
No buys this quarter
Top Sells
| 1 | +$11M | |
| 2 | +$6.65M | |
| 3 | +$1.22M | |
| 4 |
Dianthus Therapeutics
DNTH
|
+$801K |
| 5 |
Entrada Therapeutics
TRDA
|
+$672K |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Rallybio
RLYB
$22.4M
| $1.23M | 0.47% |
3,630,724
|
|
||
27
Adverum Biotechnologies
ADVM
$90M
| $1.16M | 0.45% |
541,666
|
|
||
28
Zentalis Pharmaceuticals
ZNTL
$107M
| $568K | 0.22% |
490,000
|
|
||
29
Mersana Therapeutics
MRSN
$49.3M
| $386K | 0.15% |
52,200
|
|
||
30
AnaptysBio
ANAB
$969M
| – | – |
-357,733
|
|
||
31
Cidara Therapeutics
CDTX
$2.57B
| – | – |
-56,725
|
|